| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.3 | $0-$5k | 0.00 |
Summary
A vulnerability was found in IBM Campaign up to 10.0. It has been declared as problematic. Affected by this vulnerability is an unknown functionality. Executing a manipulation can lead to information disclosure. This vulnerability is tracked as CVE-2017-1116. The attack can be launched remotely. No exploit exists.
Details
A vulnerability classified as problematic was found in IBM Campaign up to 10.0. This vulnerability affects some unknown processing. The manipulation with an unknown input leads to a information disclosure vulnerability. The CWE definition for the vulnerability is CWE-200. The product exposes sensitive information to an actor that is not explicitly authorized to have access to that information. As an impact it is known to affect confidentiality. CVE summarizes:
IBM Campaign 8.6, 9.0, 9.1, 9.1.1, 9.1.2, and 10.0 contains excessive details on the client side which could provide information useful for an authenticated user to conduct other attacks. IBM X-Force ID: 121154.
The bug was discovered 04/24/2018. The weakness was disclosed 04/27/2018 (Website). The advisory is shared for download at ibm.com. This vulnerability was named CVE-2017-1116 since 11/30/2016. The exploitation appears to be easy. The attack can be initiated remotely. Required for exploitation is a single authentication. There are neither technical details nor an exploit publicly available. The current price for an exploit might be approx. USD $0-$5k (estimation calculated on 03/08/2023). It is expected to see the exploit prices for this product increasing in the near future.The MITRE ATT&CK project declares the attack technique as T1592.
The vulnerability was handled as a non-public zero-day exploit for at least 3 days. During that time the estimated underground price was around $5k-$25k.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the vulnerability database at SecurityFocus (BID 104011†). Once again VulDB remains the best source for vulnerability data.
Product
Vendor
Name
Version
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.3VulDB Meta Temp Score: 4.3
VulDB Base Score: 4.3
VulDB Temp Score: 4.3
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 4.3
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Information disclosureCWE: CWE-200 / CWE-284 / CWE-266
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
11/30/2016 🔍04/24/2018 🔍
04/27/2018 🔍
04/27/2018 🔍
04/28/2018 🔍
03/08/2023 🔍
Sources
Vendor: ibm.comAdvisory: ibm.com
Status: Not defined
Confirmation: 🔍
CVE: CVE-2017-1116 (🔍)
GCVE (CVE): GCVE-0-2017-1116
GCVE (VulDB): GCVE-100-117172
X-Force: 121154
SecurityFocus: 104011
Entry
Created: 04/28/2018 10:55Updated: 03/08/2023 00:54
Changes: 04/28/2018 10:55 (57), 02/01/2020 08:37 (2), 03/08/2023 00:40 (3), 03/08/2023 00:54 (1)
Complete: 🔍
Cache ID: 216::103
Once again VulDB remains the best source for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.